Blog
RSS FeedPosted by Michael Wonder on 11 Dec 2022
Prices soar for antibiotics as desperate parents search for strep A medicine
11 December 2022 - Drug companies have been accused of “cartel behaviour” for increasing the costs of antibiotics during the ...
Posted by Michael Wonder on 17 Nov 2022
A tussle over medicines pricing is looming in Britain
15 November 2022 - Agreement to limit the size of the NHS drugs bill under strain. ...
Posted by Michael Wonder on 18 Mar 2022
Update to the statutory scheme to control the costs of branded health service medicines
15 March 2022 - The UK Government is seeking views on its proposal to increase the rate of payments made ...
Posted by Michael Wonder on 03 Feb 2022
Britain fines firms $47 million over price surge for NHS nausea pill
3 February 2022 - Britain's competition watchdog on Thursday fined five firms a total of 35 million pounds ($47.5 million) ...
Posted by Michael Wonder on 02 Nov 2021
Pricing vaccines and drugs in Europe: worth differentiating?
1 November 2021 - The COVID-19 pandemic has recently brought to the forefront the vital importance of vaccines, of which Europe ...
Posted by Michael Wonder on 05 Aug 2021
Pfizer epilepsy drug prices were 'unfairly high,' UK review finds
5 August 2021 - Britain's competition watchdog is sticking with its view that Pfizer and Flynn Pharma broke the law ...
Posted by Michael Wonder on 29 Jul 2021
Advanz and private equity groups fined for 1,000 per cent drug price hike
29 July 2021 - Regulator penalises pharma company and buyout firms Cinven and Hg after NHS hit by ‘unfair’ rises. ...
Posted by Michael Wonder on 15 Jul 2021
Pharma companies fined after 10,000% price rise for life saving drug
15 July 2021 - UK watchdog imposes £260 million in penalties for increases in costs of hydrocortisone tablets. ...
Posted by Michael Wonder on 18 May 2021
Northern Ireland faces ‘huge’ rise in generic medicine prices
18 May 2021 - Large increase likely after end of Brexit grace period, warns UUP head Simon Aiken. ...
Posted by Michael Wonder on 22 Apr 2021
The thorny issue of value alignment: how development-focused health technology assessment can help find win–win situations for patients and health care systems and commercial investors
20 April 2021 - We agree that there is always likely to be some tension between commercial interests and maximising societal ...
Posted by Michael Wonder on 09 Nov 2020
Vary drug prices for different conditions, say health experts
9 November 2020 - The NHS could improve patients’ access to new cancer treatments by paying different prices for drugs ...
Posted by Michael Wonder on 23 Oct 2020
Efficiency ratio and rocketing drug prices: old concerns and new possibilities
23 October 2020 - One of the most significant phenomena in the recent years concerning the pharmaceutical industry and, at ...
Posted by Michael Wonder on 15 Jun 2020
The unprecedented challenge of pricing a coronavirus vaccine
12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...
Posted by Michael Wonder on 03 Jun 2020
How a US-UK trade agreement could affect NHS drug prices
1 June 2020 - The governments of the UK and US are working on the outlines of a trade agreement. ...
Posted by Michael Wonder on 02 Mar 2020
U.K. sets red lines on drug prices, food in U.S. trade talks
2 March 2020 - Johnson’s government publishes goals for negotiations. ...